Suppr超能文献

当没有匹配时,比赛并未结束:镰状细胞病造血干细胞移植的替代供者选择。

When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease.

机构信息

Sickle Cell Branch, National Heart, Lung, and Blood Institute, Bethesda, MD; Department of Hematology, Washington Hospital Center/Georgetown University, Washington, DC.

Division of Blood and Marrow Transplantation, Children's National Health System, Washington, DC.

出版信息

Semin Hematol. 2018 Apr;55(2):94-101. doi: 10.1053/j.seminhematol.2018.04.013. Epub 2018 May 3.

Abstract

Many patients with sickle cell disease experience severe morbidity and early mortality. The only curative option remains hematopoietic stem cell transplantation. Although HLA-matched sibling transplantation has been very successful for adults and children, the vast majority of patients with sickle cell disease do not have an HLA-matched sibling. Alternative donor options include haploidentical, unrelated umbilical cord blood, and matched unrelated donor transplantation. This report summarizes major alternative donor transplantation studies reported to date and ongoing and upcoming clinical trials. We conclude that when there is no HLA-match, all these approaches should be systematically considered before ruling out the option of hematopoietic stem cell transplantation.

摘要

许多镰状细胞病患者经历严重的发病和早期死亡。唯一的根治方法仍然是造血干细胞移植。虽然 HLA 匹配的同胞供体移植对成人和儿童非常成功,但绝大多数镰状细胞病患者没有 HLA 匹配的同胞。其他供体选择包括半相合、非相关脐带血和匹配的非相关供体移植。本报告总结了迄今为止报告的主要替代供体移植研究以及正在进行和即将进行的临床试验。我们的结论是,当没有 HLA 匹配时,在排除造血干细胞移植的可能性之前,所有这些方法都应系统地考虑。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验